5/15/2019
• Posted by Provider Relations
Providers, please remember to review content available in Provider Access Online (Fidelis Care’s secure Provider Portal) and the rest of this Provider section of the Fidelis Care website. Both locations are excellent resources of information about our programs and services.
5/14/2019
• Posted by Provider Relations
Fidelis Care can help you fight opioid misuse. More people are dying of opioid overdoses than ever before in New York State. According to the State Department of Health, more than 3,000 individuals died of an opioid overdose in 2016. Buprenorphine is the first at-home medication therapy proven to be clinically effective against opioid use disorder (OUD). Buprenorphine can be an essential tool for helping you treat your OUD patients.
5/7/2019
• Posted by Provider Relations
*Attention Specialty Medication Prescribers *
This notice is to provide information regarding specialty medications. Members can obtain covered specialty drugs at any retail pharmacy in Fidelis Care’s network, as long as that retail network pharmacy accepts Fidelis Care’s specialty network terms and conditions. If your patient has difficulty obtaining this medication from his or her preferred network pharmacy, AcariaHealth...
4/30/2019
• Posted by Provider Relations
Fidelis Care is pleased to inform you that the most recent 2019 QARR Non-Compliance Report has been posted on Provider Access Online (provider portal). This information is indicative of all encounter data on file with Fidelis Care as of 03/18/2019.
4/29/2019
• Posted by Fidelis Care
The following sections of the Fidelis Care authorization grids have been updated effective June 1, 2019.
Newer Articles
Older Articles